SCHEMBL8326400

SCHEMBL8326400

O=C(O)C(CCc1cccs1)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.67
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49
POLB P06746 3/20 0.49
TDP1 Q9NUW8 1/20 0.49
TAAR1 Q96RJ0 2/20 0.48
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 3/20 0.45
ADRA2A P08913 2/20 0.44
ADRA2B P18089 2/20 0.44
ADRA2C P18825 2/20 0.44
LMNA P02545 1/20 0.44
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27346489 0.89 CYP2C19 (0.62) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL9584558 0.84 CYP2C19 (0.56) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL28744154 0.84 CYP2C19 (0.56) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL7275819 0.84 CYP2C19 (0.56) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL28672259 0.81 CYP2C19 (0.53) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL1766985 0.80 CYP2C19 (1.00) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL654985 0.80 POLB (0.66) CYP2C19POLBTDP1TAAR1NPC1
SCHEMBL11836175 0.80 CYP2C19 (0.51) CYP2C19SLC1A3SLC1A2SLC1A1POLB
SCHEMBL8332586 0.80 SMN1; SMN2 (0.48) CYP2C19POLBTDP1NPC1RAB9A
SCHEMBL6753453 0.79 CYP2C19 (0.54) CYP2C19SLC1A3SLC1A2SLC1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908863-A ANTIGROWTH AGENT FOR BONES DOMPE' S.P.A. (IT) 1999-06-01 US disclosed
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed